Treatment of vision disorders using electrical, light, and/or sound energy
A non-invasive ocular therapy for vision disorders is provided. First and second electrodes of a direct current source are electrically contacted so as to deliver current to and/or about an area proximal one or more eyes of a subject. A direct electrical current of between about 1-800 microamps, at a resistance assumption of about 500 ohms, is generated between the electrodes for a preselected duration. Preferably, the direct electrical current is generated at a select frequency profile as a function of time, and with a carrier signal of about 10,000-12,000 hertz. Advantageously, the subject therapy is augmented via application of light energy to the eye(s), as well as by the application of infrasonic sound waves directly into eyes.
1. A non-invasive ocular therapy for vision disorders comprising:
a. positioning a first electrode on or proximate to an eyelid of a subject;
b. positioning a second electrode on the subject; and
c. generating an electric current between said electrodes of between 1-800 microamps wherein the electrical current is generated at multiple frequencies and modulated with a carrier signal in a range of about 10,000 hertz to less than 12,000 hertz.
2. The therapy of claim 1 wherein said electrical current is generated at about 292 hertz for about one minute.
3. The therapy of claim 1 wherein said electrical current is generated at about 8-9 hertz for at least seven minutes.
4. The therapy of claim 1 wherein said electrical current is generated at about 0.15-0.3 hertz for at least seven minutes.
5. The therapy of claim 1 wherein said carrier signal is modulated on and off.
6. The therapy of claim 5 wherein said carrier signal is inverted by reversing a polarity thereof at said electrodes.
7. The therapy of claim 6 wherein said carrier signal is inverted about every 0.05 seconds.
8. The therapy of claim 1 further comprising the application of light energy to the eye of the subject at a power density of up to about 4.5 joules per centimeter squared.
9. The therapy of claim 8 wherein said light energy has an optical power of about 5 milliwatts per centimeter squared.
10. The therapy of claim 9 wherein said light energy is applied at a frequency of about 145 hertz for up to about 15 minutes.
11. The therapy of claim 10 wherein said light energy is characterized by wavelength ranges of about 450-500 nanometers, 520-570 nanometers, 565-590 nanometers or 625-740 nanometers.
12. The therapy of claim 11 wherein applying said light energy is conducted upon each eye of the subject sequentially characterized by first and second wavelength ranges.
13. The therapy of claim 12 wherein said first wavelength range is 450-500 nanometers.
14. The therapy of claim 13 wherein said second wavelength range comprises about 520-570 nanometers.
15. The therapy of claim 12 wherein said first wavelength range comprises about 520-570 nanometers.
16. The therapy of claim 15 wherein said second wavelength range comprises about 450-500 nanometers.
17. The therapy of claim 12 wherein said first wavelength range comprises about 565-590 nanometers.
18. The therapy of claim 17 wherein said second wavelength range comprises about 625-740 nanometers.
19. The therapy of claim 12 wherein said first wavelength range comprises about 625-740 nanometers.
20. The therapy of claim 19 wherein said second wavelength range comprises about 565-590 nanometers.
21. The therapy of claim 1 further comprising the application of infrasonic sound waves directly into eyes of the subject.
22. The therapy of claim 21 wherein said infrasonic sound waves are characterized by frequencies from about 8-14 hertz.
23. A non-invasive ocular therapy for vision disorders comprising:
a. positioning a first electrode on or proximate to an eyelid of a subject;
b. positioning a second electrode to on the subject; and
c. generating an electrical current between said electrodes of between 1- 800 microamps wherein said electrical current is generated at a selected frequency profile of multiple frequencies and modulated with a carrier signal of about 10,000 hertz to less than 12,000 hertz.
24. The therapy of claim 23 wherein said frequency profile comprises about 292 hertz for about one minute, about 31 hertz for about 2 minutes, about 8-9 hertz for at least seven minutes, and about 0.15-0.3 hertz for at least seven minutes.
25. The therapy of claim 23 further comprising the application of infrasonic sound waves directly into the eyes of the subject.
26. The therapy of claim 25 wherein said infrasonic sound waves are characterized by frequencies from about 8-14 hertz.